REPORT ID 954

Global Granulocyte-Colony Stimulating Factor Market Professional Survey Report 2017

Publish Date
04-Dec-17
Pages
117
Format
Electronic (PDF)

This report studies Granulocyte-Colony Stimulating Factor in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Biocad
    Celltrion Inc
    Dong-A Socio Group
    Pfizer Inc
    Intas Pharmaceuticals Ltd
    Novartis
    Stada Arzneimittel AG
    Teva Pharmaceutical Industries Ltd
    Amgen Inc
    Biocon
    Dr. Reddy's Laboratories
    Mylan
    Merck KGaA

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Capsule
    Tablet
    Others

By Application, the market can be split into
    Oncology
    Blood Disorders
    Growth Hormone Deficiencies
    Chronic and Autoimmune Disorders
    Other Applications

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Granulocyte-Colony Stimulating Factor Market Professional Survey Report 2017
1 Industry Overview of Granulocyte-Colony Stimulating Factor
    1.1 Definition and Specifications of Granulocyte-Colony Stimulating Factor
        1.1.1 Definition of Granulocyte-Colony Stimulating Factor
        1.1.2 Specifications of Granulocyte-Colony Stimulating Factor
    1.2 Classification of Granulocyte-Colony Stimulating Factor
        1.2.1 Capsule
        1.2.2 Tablet
        1.2.3 Others
    1.3 Applications of Granulocyte-Colony Stimulating Factor
        1.3.1 Oncology
        1.3.2 Blood Disorders
        1.3.3 Growth Hormone Deficiencies
        1.3.4 Chronic and Autoimmune Disorders
        1.3.5 Other Applications
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Granulocyte-Colony Stimulating Factor
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Granulocyte-Colony Stimulating Factor
    2.3 Manufacturing Process Analysis of Granulocyte-Colony Stimulating Factor
    2.4 Industry Chain Structure of Granulocyte-Colony Stimulating Factor

3 Technical Data and Manufacturing Plants Analysis of Granulocyte-Colony Stimulating Factor
    3.1 Capacity and Commercial Production Date of Global Granulocyte-Colony Stimulating Factor Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Granulocyte-Colony Stimulating Factor Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Granulocyte-Colony Stimulating Factor Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Granulocyte-Colony Stimulating Factor Major Manufacturers in 2016

4 Global Granulocyte-Colony Stimulating Factor Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Granulocyte-Colony Stimulating Factor Capacity and Growth Rate Analysis
        4.2.2 2016 Granulocyte-Colony Stimulating Factor Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Granulocyte-Colony Stimulating Factor Sales and Growth Rate Analysis
        4.3.2 2016 Granulocyte-Colony Stimulating Factor Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Granulocyte-Colony Stimulating Factor Sales Price
        4.4.2 2016 Granulocyte-Colony Stimulating Factor Sales Price Analysis (Company Segment)

5 Granulocyte-Colony Stimulating Factor Regional Market Analysis
    5.1 North America Granulocyte-Colony Stimulating Factor Market Analysis
        5.1.1 North America Granulocyte-Colony Stimulating Factor Market Overview
        5.1.2 North America 2012-2017E Granulocyte-Colony Stimulating Factor Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Granulocyte-Colony Stimulating Factor Sales Price Analysis
        5.1.4 North America 2016 Granulocyte-Colony Stimulating Factor Market Share Analysis
    5.2 China Granulocyte-Colony Stimulating Factor Market Analysis
        5.2.1 China Granulocyte-Colony Stimulating Factor Market Overview
        5.2.2 China 2012-2017E Granulocyte-Colony Stimulating Factor Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Granulocyte-Colony Stimulating Factor Sales Price Analysis
        5.2.4 China 2016 Granulocyte-Colony Stimulating Factor Market Share Analysis
    5.3 Europe Granulocyte-Colony Stimulating Factor Market Analysis
        5.3.1 Europe Granulocyte-Colony Stimulating Factor Market Overview
        5.3.2 Europe 2012-2017E Granulocyte-Colony Stimulating Factor Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Granulocyte-Colony Stimulating Factor Sales Price Analysis
        5.3.4 Europe 2016 Granulocyte-Colony Stimulating Factor Market Share Analysis
    5.4 Southeast Asia Granulocyte-Colony Stimulating Factor Market Analysis
        5.4.1 Southeast Asia Granulocyte-Colony Stimulating Factor Market Overview
        5.4.2 Southeast Asia 2012-2017E Granulocyte-Colony Stimulating Factor Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Granulocyte-Colony Stimulating Factor Sales Price Analysis
        5.4.4 Southeast Asia 2016 Granulocyte-Colony Stimulating Factor Market Share Analysis
    5.5 Japan Granulocyte-Colony Stimulating Factor Market Analysis
        5.5.1 Japan Granulocyte-Colony Stimulating Factor Market Overview
        5.5.2 Japan 2012-2017E Granulocyte-Colony Stimulating Factor Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Granulocyte-Colony Stimulating Factor Sales Price Analysis
        5.5.4 Japan 2016 Granulocyte-Colony Stimulating Factor Market Share Analysis
    5.6 India Granulocyte-Colony Stimulating Factor Market Analysis
        5.6.1 India Granulocyte-Colony Stimulating Factor Market Overview
        5.6.2 India 2012-2017E Granulocyte-Colony Stimulating Factor Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Granulocyte-Colony Stimulating Factor Sales Price Analysis
        5.6.4 India 2016 Granulocyte-Colony Stimulating Factor Market Share Analysis

6 Global 2012-2017E Granulocyte-Colony Stimulating Factor Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Granulocyte-Colony Stimulating Factor Sales by Type
    6.2 Different Types of Granulocyte-Colony Stimulating Factor Product Interview Price Analysis
    6.3 Different Types of Granulocyte-Colony Stimulating Factor Product Driving Factors Analysis
        6.3.1 Capsule of Granulocyte-Colony Stimulating Factor Growth Driving Factor Analysis
        6.3.2 Tablet of Granulocyte-Colony Stimulating Factor Growth Driving Factor Analysis
        6.3.3 Others of Granulocyte-Colony Stimulating Factor Growth Driving Factor Analysis

7 Global 2012-2017E Granulocyte-Colony Stimulating Factor Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Granulocyte-Colony Stimulating Factor Consumption by Application
    7.2 Different Application of Granulocyte-Colony Stimulating Factor Product Interview Price Analysis
    7.3 Different Application of Granulocyte-Colony Stimulating Factor Product Driving Factors Analysis
        7.3.1 Oncology of Granulocyte-Colony Stimulating Factor Growth Driving Factor Analysis
        7.3.2 Blood Disorders of Granulocyte-Colony Stimulating Factor Growth Driving Factor Analysis
        7.3.3 Growth Hormone Deficiencies of Granulocyte-Colony Stimulating Factor Growth Driving Factor Analysis
        7.3.4 Chronic and Autoimmune Disorders of Granulocyte-Colony Stimulating Factor Growth Driving Factor Analysis
        7.3.5 Other Applications of Granulocyte-Colony Stimulating Factor Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Granulocyte-Colony Stimulating Factor
    8.1 Biocad
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Biocad 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Biocad 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.2 Celltrion Inc
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Celltrion Inc 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Celltrion Inc 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.3 Dong-A Socio Group
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Dong-A Socio Group 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Dong-A Socio Group 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.4 Pfizer Inc
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Pfizer Inc 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Pfizer Inc 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.5 Intas Pharmaceuticals Ltd
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Intas Pharmaceuticals Ltd 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Intas Pharmaceuticals Ltd 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.6 Novartis
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Novartis 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Novartis 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.7 Stada Arzneimittel AG
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Stada Arzneimittel AG 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Stada Arzneimittel AG 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.8 Teva Pharmaceutical Industries Ltd
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Teva Pharmaceutical Industries Ltd 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Teva Pharmaceutical Industries Ltd 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.9 Amgen Inc
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Amgen Inc 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Amgen Inc 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.10 Biocon
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Biocon 2016 Granulocyte-Colony Stimulating Factor Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Biocon 2016 Granulocyte-Colony Stimulating Factor Business Region Distribution Analysis
    8.11 Dr. Reddy's Laboratories
    8.12 Mylan
    8.13 Merck KGaA

9 Development Trend of Analysis of Granulocyte-Colony Stimulating Factor Market
    9.1 Global Granulocyte-Colony Stimulating Factor Market Trend Analysis
        9.1.1 Global 2017-2022 Granulocyte-Colony Stimulating Factor Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Granulocyte-Colony Stimulating Factor Sales Price Forecast
    9.2 Granulocyte-Colony Stimulating Factor Regional Market Trend
        9.2.1 North America 2017-2022 Granulocyte-Colony Stimulating Factor Consumption Forecast
        9.2.2 China 2017-2022 Granulocyte-Colony Stimulating Factor Consumption Forecast
        9.2.3 Europe 2017-2022 Granulocyte-Colony Stimulating Factor Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Granulocyte-Colony Stimulating Factor Consumption Forecast
        9.2.5 Japan 2017-2022 Granulocyte-Colony Stimulating Factor Consumption Forecast
        9.2.6 India 2017-2022 Granulocyte-Colony Stimulating Factor Consumption Forecast
    9.3 Granulocyte-Colony Stimulating Factor Market Trend (Product Type)
    9.4 Granulocyte-Colony Stimulating Factor Market Trend (Application)

10 Granulocyte-Colony Stimulating Factor Marketing Type Analysis
    10.1 Granulocyte-Colony Stimulating Factor Regional Marketing Type Analysis
    10.2 Granulocyte-Colony Stimulating Factor International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Granulocyte-Colony Stimulating Factor by Region
    10.4 Granulocyte-Colony Stimulating Factor Supply Chain Analysis

11 Consumers Analysis of Granulocyte-Colony Stimulating Factor
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Granulocyte-Colony Stimulating Factor Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source